Suppr超能文献

Efficacy of a twelve-hourly ceftriaxone regimen in the treatment of serious bacterial infections.

作者信息

Maslow M J, Levine J F, Pollock A A, Simberkoff M S, Rahal J J

出版信息

Antimicrob Agents Chemother. 1982 Jul;22(1):103-7. doi: 10.1128/AAC.22.1.103.

Abstract

Eighteen patients with 21 serious infections were treated with ceftriaxone, 1 g intravenously every 12 h, for a mean duration of 8 days. Eighteen gram-negative and two gram-positive organisms were isolated. Sites of infection included blood (three patients), urinary tract (six patients), respiratory tract (seven patients), biliary tract (three patients), ascitic fluid (one patient), and skin (one patient). Serum, bile, and ascitic fluid concentrations of ceftriaxone were in excess of the minimal bactericidal concentration required for the infecting organism in all cases. A bacteriological response was demonstrated in 94% of the infections. A clinical response occurred in four infections from which no pathogens were recovered. In one patient, ceftriaxone failed to eradicate a peritoneal infection due to Bacteroides fragilis. In two patients, superinfection with enterococci developed both during and after therapy. Systemic tolerance to ceftriaxone was excellent.

摘要

相似文献

1
Efficacy of a twelve-hourly ceftriaxone regimen in the treatment of serious bacterial infections.
Antimicrob Agents Chemother. 1982 Jul;22(1):103-7. doi: 10.1128/AAC.22.1.103.
2
Ceftriaxone therapy of serious bacterial infections in adults.
Antimicrob Agents Chemother. 1983 Feb;23(2):261-6. doi: 10.1128/AAC.23.2.261.
3
Efficacy of ceftriaxone in serious bacterial infections.
Antimicrob Agents Chemother. 1982 Mar;21(3):402-6. doi: 10.1128/AAC.21.3.402.
4
Clinical evaluation of ceftriaxone.
Clin Ther. 1984;6(5):653-61.
5
Ceftriaxone therapy of serious bacterial infections.
J Antimicrob Chemother. 1983 Jul;12(1):65-78. doi: 10.1093/jac/12.1.65.
6
[Clinical evaluation of ceftriaxone in the pediatric field].
Jpn J Antibiot. 1984 Nov;37(11):2027-33.
7
Ceftriaxone therapy of bone and soft tissue infections in hospital and outpatient settings.
Antimicrob Agents Chemother. 1983 May;23(5):731-7. doi: 10.1128/AAC.23.5.731.
8
Ceftriaxone (Ro 13-9904) therapy of serious infection.
Antimicrob Agents Chemother. 1982 Jul;22(1):36-42. doi: 10.1128/AAC.22.1.36.

引用本文的文献

1
Infections due to antibiotic-resistant gram-positive cocci.
J Gen Intern Med. 1993 Nov;8(11):626-34. doi: 10.1007/BF02599723.
3
Ceftriaxone. A review of its antibacterial activity, pharmacological properties and therapeutic use.
Drugs. 1984 Jun;27(6):469-527. doi: 10.2165/00003495-198427060-00001.
5
Once-daily ceftriaxone for skin and soft tissue infections.
Antimicrob Agents Chemother. 1985 Apr;27(4):648-9. doi: 10.1128/AAC.27.4.648.
6
Clinical pharmacokinetics of ceftriaxone.
Clin Pharmacokinet. 1989 Oct;17(4):223-35. doi: 10.2165/00003088-198917040-00002.
7
Pathogenicity of the enterococcus in surgical infections.
Ann Surg. 1990 Aug;212(2):155-9. doi: 10.1097/00000658-199008000-00007.

本文引用的文献

1
Pharmacokinetics of Ro 13-9904, a broad-spectrum cephalosporin.
Antimicrob Agents Chemother. 1980 Aug;18(2):240-2. doi: 10.1128/AAC.18.2.240.
3
Ro 13-9904, a long-acting broad-spectrum cephalosporin: in vitro and in vivo studies.
Antimicrob Agents Chemother. 1980 Dec;18(6):913-21. doi: 10.1128/AAC.18.6.913.
4
In vitro antibacterial activity and susceptibility of the cephalosporin Ro 13-9904 to beta-lactamases.
Antimicrob Agents Chemother. 1980 Aug;18(2):292-8. doi: 10.1128/AAC.18.2.292.
5
In vitro evaluation of Ro 13-9904.
Antimicrob Agents Chemother. 1980 Oct;18(4):574-8. doi: 10.1128/AAC.18.4.574.
6
Pharmacokinetics of ceftriaxone in humans.
Antimicrob Agents Chemother. 1981 Nov;20(5):634-41. doi: 10.1128/AAC.20.5.634.
8
In vivo activity of ceftriaxone (Ro 13-9904), a new broad-spectrum semisynthetic cephalosporin.
Antimicrob Agents Chemother. 1981 Aug;20(2):159-67. doi: 10.1128/AAC.20.2.159.
10
LY-127935: a novel beta-lactam antibiotic with unusual antibacterial activity.
Antimicrob Agents Chemother. 1979 Sep;16(3):297-300. doi: 10.1128/AAC.16.3.297.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验